Senti Biosciences

View the org chart displaying its 13 main executives

Most searched biographies at Senti Biosciences

• Tim Lu, Chief Executive Officer and Director
• Brenda Cooperstone, Director
• James Collins, Director

Popular executive movements at Senti Biosciences

• Deborah Knobelman, Chief Financial Officer & Head of Corporate Development, has left the company  (posted on May 19 2024).

Create your alert
to follow the executive moves at Senti Biosciences.

Senti Biosciences has 2,297 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Johnson & Johnson has announced the acquisition of Proteologix  (posted on May 20 2024).
• Rapport Therapeutics has just announced a $100 Million fundraising (posted on May 20 2024).
• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Senti Biosciences

• Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML) | Senti Biosciences, Inc.
• Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML) | Senti Biosciences, Inc.
• Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights | Senti Biosciences, Inc.
• Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights | Senti Biosciences, Inc.
• Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China | Senti Biosciences, Inc.
• Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China | Senti Biosciences, Inc.
• Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual Meeting | Senti Biosciences, Inc.
• Senti Bio Announces Multiple Data Presentations at the Society for Immunotherapy of Cancer Annual Meeting | Senti Biosciences, Inc.
• Senti Bio to Participate in Upcoming Investor Conferences | Senti Biosciences, Inc.
• Senti Bio to Participate in Upcoming Investor Conferences | Senti Biosciences, Inc.
• View more press releases Close

Social media about Senti Biosciences

• Senti Biosciences on Wikipedia, Google News & Yahoo Finance
• Senti Biosciences on LinkedIn, Twitter & YouTube

Contact by email its executives including Tim Lu

Call Senti Biosciences at +1 510...

View the org chart

Register to receive your alert

Report an error